Total Payments
$295,667
2024 Payments
$80,644
Companies
12
Transactions
193
Payment Breakdown by Category
Consulting$191,226 (64.7%)
Other$66,470 (22.5%)
Travel$27,778 (9.4%)
Education$5,645 (1.9%)
Food & Beverage$3,477 (1.2%)
Research$1,071 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $191,226 | 64 | 64.7% |
| Honoraria | $51,767 | 24 | 17.5% |
| Travel and Lodging | $27,778 | 41 | 9.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,929 | 3 | 3.4% |
| Education | $5,645 | 2 | 1.9% |
| Food and Beverage | $3,477 | 56 | 1.2% |
| Grant | $2,500 | 1 | 0.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,275 | 1 | 0.8% |
| Unspecified | $1,071 | 1 | 0.4% |
Payments by Type
General
$294,596
192 transactions
Research
$1,071
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Agios Pharmaceuticals, Inc. | $109,338 | 71 | $0 (2024) |
| Celgene Corporation | $83,265 | 50 | $0 (2024) |
| VERTEX PHARMACEUTICALS INCORPORATED | $51,084 | 41 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $32,239 | 14 | $0 (2024) |
| Acceleron Pharma, Inc. | $5,940 | 2 | $0 (2020) |
| APO-PHARMA INC. | $3,469 | 3 | $0 (2019) |
| Kedrion Biopharma Inc. | $2,500 | 1 | $0 (2017) |
| Octapharma USA, Inc. | $2,500 | 1 | $0 (2024) |
| Novo Nordisk Health Care AG | $2,380 | 2 | $0 (2024) |
| Chiesi USA, Inc. | $1,694 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $80,644 | 60 | Agios Pharmaceuticals, Inc. ($42,469) |
| 2023 | $50,841 | 26 | Agios Pharmaceuticals, Inc. ($22,137) |
| 2022 | $44,553 | 30 | Agios Pharmaceuticals, Inc. ($27,734) |
| 2021 | $16,015 | 9 | Celgene Corporation ($8,589) |
| 2020 | $40,534 | 19 | Agios Pharmaceuticals, Inc. ($15,758) |
| 2019 | $41,739 | 33 | Celgene Corporation ($32,392) |
| 2018 | $14,426 | 12 | Celgene Corporation ($14,047) |
| 2017 | $6,915 | 4 | APO-PHARMA INC. ($3,344) |
All Payment Transactions
193 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Honoraria | Cash or cash equivalent | $9,246.66 | General |
| Category: Genetically Defined Disease | ||||||
| 12/17/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Consulting Fee | Cash or cash equivalent | $555.00 | General |
| Category: Genetically Defined Disease | ||||||
| 12/16/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Consulting Fee | Cash or cash equivalent | $1,110.00 | General |
| Category: Genetically Defined Disease | ||||||
| 12/10/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Consulting Fee | Cash or cash equivalent | $2,775.00 | General |
| Category: Genetically Defined Disease | ||||||
| 12/10/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $72.00 | General |
| 12/10/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $29.40 | General |
| 12/09/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $57.64 | General |
| Category: Genetically Defined Disease | ||||||
| 12/07/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: Genetically Defined Disease | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| 12/03/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| Category: Genetically Defined Disease | ||||||
| 11/19/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $131.94 | General |
| Category: Genetically Defined Disease | ||||||
| 11/11/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Consulting Fee | Cash or cash equivalent | $693.75 | General |
| Category: Genetically Defined Disease | ||||||
| 11/07/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Honoraria | Cash or cash equivalent | $1,000.00 | General |
| Category: Genetically Defined Disease | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $270.00 | General |
| 11/01/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Consulting Fee | Cash or cash equivalent | $555.00 | General |
| Category: Genetically Defined Disease | ||||||
| 10/22/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Honoraria | Cash or cash equivalent | $2,775.00 | General |
| Category: Genetically Defined Disease | ||||||
| 10/22/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $134.51 | General |
| Category: Genetically Defined Disease | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $4,775.00 | General |
| 10/01/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Travel and Lodging | Cash or cash equivalent | $768.60 | General |
| Category: Genetically Defined Disease | ||||||
| 10/01/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: Genetically Defined Disease | ||||||
| 09/20/2024 | Celgene Corporation | — | Travel and Lodging | Cash or cash equivalent | $214.81 | General |
| 09/19/2024 | Celgene Corporation | — | Travel and Lodging | Cash or cash equivalent | $214.81 | General |
| 09/18/2024 | Celgene Corporation | — | Travel and Lodging | Cash or cash equivalent | $7,187.45 | General |
| 09/18/2024 | Celgene Corporation | — | Travel and Lodging | Cash or cash equivalent | $214.81 | General |
| 09/18/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $56.09 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| HEOR | Celgene Corporation | $1,071 | 1 |
About Sujit Sheth
Sujit Sheth is a Pediatric Hematology-Oncology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841263878.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sujit Sheth has received a total of $295,667 in payments from pharmaceutical and medical device companies, with $80,644 received in 2024. These payments were reported across 193 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($191,226).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location New York, NY
- Active Since 02/09/2006
- Last Updated 02/04/2008
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1841263878
Products in Payments
- PYRUKYND (Drug) $92,251
- Luspatercept (Drug) $30,556
- REBLOZYL (Biological) $27,902
- Reblozyl (Drug) $5,940
- FERRIPROX 500 MG/1 TABLET (Drug) $3,344
- Koate (Drug) $2,500
- NUWIQ (Biological) $2,500
- Revlimid (Drug) $1,071
- HEMLIBRA (Biological) $274.91
- FERRIPROX (Drug) $243.50
- TIBSOVO (Drug) $140.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in New York
Dr. Jaap-Jan Boelens, Md, Phd, MD, PHD
Pediatric Hematology-Oncology — Payments: $265,256
Pediatric Hematology-Oncology $265,256
James Ferrara, Md, MD
Pediatric Hematology-Oncology — Payments: $142,558
Pediatric Hematology-Oncology $142,558
Dr. Catherine Mcguinn, M.d, M.D
Pediatric Hematology-Oncology — Payments: $100,798
Pediatric Hematology-Oncology $100,798
Saara Kaviany, D.o, D.O
Pediatric Hematology-Oncology — Payments: $91,703
Pediatric Hematology-Oncology $91,703
Ira Dunkel, Md, MD
Pediatric Hematology-Oncology — Payments: $60,181
Pediatric Hematology-Oncology $60,181
Dr. Lisa Roth, Md, MD
Pediatric Hematology-Oncology — Payments: $48,991
Pediatric Hematology-Oncology $48,991